Prevalence and Correlates of Hypophosphatemia Among Type 2 diabetic patients attending the National Center for Diabetes, Endocrinology and genetics (NCDEG)
- PMID: 35592823
- PMCID: PMC9110974
- DOI: 10.1016/j.amsu.2022.103770
Prevalence and Correlates of Hypophosphatemia Among Type 2 diabetic patients attending the National Center for Diabetes, Endocrinology and genetics (NCDEG)
Abstract
Objectives: To estimate the prevalence of hypophosphatemia and its associated factors among type 2 diabetic patients attending (NCDEG) in Amman-Jordan, and compare the prevalence of hypophosphatemia between diabetics, nondiabetic subjects.
Patients and methods: A case-control study was carried out at (NCDEG). A total of 1580 diabetic patients (59.7% females, 40.3% males), mean age (SD) of 55.15 ± 15.3 attended this center from January 1st, 2020 till March 31st, 2020 were included. Our study included 2155 non-diabetic from the national population-based multipurpose study in Jordan in 2017, to compare serum inorganic phosphate between diabetic, nondiabetic. Pregnant, those aged <18 or >80 years, GFR below 30 ml/min or those on hemodialysis were excluded. The data included patient's age, gender, smoking and medication, HbA1c. Statistical analysis were performed using the Package for Social Sciences (SPSS) version 21.
Results: The overall prevalence of hypophosphatemia in the diabetic patients was significantly higher (10.5% vs. 3.2%, P-value 0.001). Multivariate logistic regression analysis showed that in diabetic: males, current smokers, diabetic patients with HbA1c between 7 and 9% and >9%, those who on thiazide diuretics were 2, 1.9, 1.8, 1.7, and 1.9 times, more likely to have hypophosphatemia than their counterparts (P-values 0.001, 0.001, 0.006, 0.018 and 0.003), respectively, and it was found those on statin were less likely to have hypophosphatemia.
Conclusion: The prevalence of hypophosphatemia among type 2 diabetic patients is high. Factors independently related to hypophosphatemia in diabetic patients: male gender, smoking, poor glycemic control, taking thiazides and not being on statin.
Keywords: Associated factors; Hypophosphatemia; Prevalence; Type 2 diabetes mellitus.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Prevalence of Hypomagnesaemia among Obese Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology and Genetics (NCDEG).Int J Endocrinol Metab. 2014 Jul 1;12(3):e17796. doi: 10.5812/ijem.17796. eCollection 2014 Jul. Int J Endocrinol Metab. 2014. PMID: 25237327 Free PMC article.
-
Prevalence and risk factors of diabetic retinopathy among Jordanian patients with type 2 diabetes.Digit J Ophthalmol. 2008 Aug 4;14:42-49. doi: 10.5693/djo.01.2008.013. eCollection 2008. Digit J Ophthalmol. 2008. PMID: 29440980 Free PMC article.
-
Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors.Front Public Health. 2022 Nov 8;10:1002466. doi: 10.3389/fpubh.2022.1002466. eCollection 2022. Front Public Health. 2022. PMID: 36424970 Free PMC article.
-
Sleep Quality in Patients With Type 2 Diabetes Mellitus.J Clin Med Res. 2019 Apr;11(4):261-266. doi: 10.14740/jocmr2947w. Epub 2019 Mar 18. J Clin Med Res. 2019. PMID: 30937116 Free PMC article.
-
Prevalence and predictors of diabetic foot syndrome in type 2 diabetes mellitus in Jordan.Saudi Med J. 2003 Jul;24(7):761-4. Saudi Med J. 2003. PMID: 12883610
Cited by
-
Osteomalacia in Adults: A Practical Insight for Clinicians.J Clin Med. 2023 Apr 5;12(7):2714. doi: 10.3390/jcm12072714. J Clin Med. 2023. PMID: 37048797 Free PMC article. Review.
-
Assessment of Electrolyte Imbalance and Associated Factors Among Adult Diabetic Patients Attending the University of Gondar Comprehensive Specialized Hospital, Ethiopia: A Comparative Cross-Sectional Study.Diabetes Metab Syndr Obes. 2023 Apr 26;16:1207-1220. doi: 10.2147/DMSO.S404788. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37131504 Free PMC article.
References
-
- Knochel J.P. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch. Intern. Med. 1977;137(2):203–220. . - PubMed
-
- Gaasbeek A., Meinders A.E. Hypophosphatemia: an update on its etiology and treatment. Am. J. Med. 2005;118(10):1094–1101. . - PubMed
-
- Felsenfeld A.J., Levine B.S. Approach to treatment of hypophosphatemia. Am. J. Kidney Dis. 2012;60(4):655–661. . - PubMed
LinkOut - more resources
Full Text Sources